Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to HODGKIN LYMPHOMA (HL)

ASH Clinical News

Long-Term Childhood Hodgkin Lymphoma (HL) Survivors Have Increased Risk of Neurocognitive Impairment

Hematology/Oncology March 29th 2022

Journal of Clinical Oncology

Hodgkin Lymphoma: PET-Adaptive Approach in Bulky Hodgkin Lymphoma

Hematology January 19th 2022

Journal of Clinical Oncology

Phase II Trial of Pembrolizumab + Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as SLT for Rel/Ref Classical Hodgkin Lymphoma (cHL)

Hematology December 21st 2021

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form